{"organizations": [], "uuid": "46fec06935cc553abfe6de70c226d05442e00bec", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/5", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/18/pr-newswire-biomarin-to-host-first-quarter-2018-financial-results-conference-call-and-webcast-on-wednesday-april-25-at-430pm-et.html", "country": "US", "domain_rank": 767, "title": "BioMarin to Host First Quarter 2018 Financial Results Conference Call and Webcast on Wednesday, April 25 at 4:30pm ET", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.23, "site_type": "news", "published": "2018-04-18T16:30:00.000+03:00", "replies_count": 0, "uuid": "46fec06935cc553abfe6de70c226d05442e00bec"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/18/pr-newswire-biomarin-to-host-first-quarter-2018-financial-results-conference-call-and-webcast-on-wednesday-april-25-at-430pm-et.html", "ord_in_thread": 0, "title": "BioMarin to Host First Quarter 2018 Financial Results Conference Call and Webcast on Wednesday, April 25 at 4:30pm ET", "locations": [], "entities": {"persons": [{"name": "jean-jacques bienaimé", "sentiment": "none"}], "locations": [{"name": "san rafael", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "canada", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "biomarin", "sentiment": "negative"}, {"name": "biomarin pharmaceutical inc.", "sentiment": "negative"}, {"name": "biomarin biomarin", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN RAFAEL, Calif., April 18, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, April 25, at 4:30 p.m. ET to discuss first quarter 2018 financial results and provide a general business update.\nDial-in Number\nU.S. / Canada Dial-in Number: (866) 502-9859\nInternational Dial-in Number: (574) 990-1362\nConference ID: 1665515\nReplay Dial-in Number: (855) 859-2056\nReplay International Dial-in Number: (404) 537-3406\nConference ID: 1665515\nInterested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com . A replay of the call will be archived on the site for one week following the call.\nAbout BioMarin\nBioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com .\nContacts:\nInvestors\nMedia\nTraci McCarty\nDebra Charlesworth\nBioMarin Pharmaceutical Inc.\nBioMarin Pharmaceutical Inc.\n(415) 455-7558\n(415) 455-7451\nView original content with multimedia: http://www.prnewswire.com/news-releases/biomarin-to-host-first-quarter-2018-financial-results-conference-call-and-webcast-on-wednesday-april-25-at-430pm-et-300631293.html\nSOURCE BioMarin Pharmaceutical Inc.", "external_links": ["http://www.prnewswire.com/news-releases/biomarin-to-host-first-quarter-2018-financial-results-conference-call-and-webcast-on-wednesday-april-25-at-430pm-et-300631293.html", "http://www.biomarin.com/"], "published": "2018-04-18T16:30:00.000+03:00", "crawled": "2018-04-18T17:42:44.005+03:00", "highlightTitle": ""}